In this podcast, an expert discusses decision making for subsequent line therapy for advanced gastric cancer, and review cases, followed by a question-and-answer session about practical considerations for case management. Claim your credit at pce.is/GIGU.
In this second of two podcasts, an expert discuss decision making for subsequent line therapy for advanced gastric cancer, and review cases to illustrate practical considerations, followed by a question-and-answer session. This activity is available for CE/CME credit. Claim your credit at pce.is/GIGU.
Contributor:
David Ilson, MD
Dr Ilson: consulting fees: Aeris, Amgen, Astellas, AstraZeneca, Bayer, Bristol-Myers Squibb, Lilly, Merck, Roche, Taiho.